IL-12 TAVO
Intratumoral
Cancer Immunotherapy

Learn More About OncoSec

Key Opinion Leader Symposium Webcast     Key Opinion Leader Symposium Transcript

Corporate Presentation     AACR 2019 Poster

ROTH Conference Webcast     KEYNOTE-695 SITC Poster

TAVO Demonstration     SABCS Posters

Clinical trials of today may power
the medical advances of tomorrow.

Learn more about our current clinical trials:

Advanced Melanoma     Triple Negative Breast Cancer

Spotlight 

Nature Gene Therapy: Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy

Immuno-Oncology News: TAVO reverses resistance to PD-1 inhibitors in metastatic melanoma, phase 2b trial suggests

Health Professionals Radio: President and CEO Dan O’Connor discusses late-stage studies in melanoma and TNBC.

News & Events

Apr 17, 2019
OncoSec Announces Collaborative Research Agreement in HER2+ Breast Cancer Evaluating the Use of TAVO™ in Combination with Plasmid DNA Vaccines with a World Leading Academic Medical Center
Apr 10, 2019
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
Apr 9, 2019
OncoSec to Present at H.C. Wainwright Global Life Sciences Conference
Apr 8, 2019
OncoSec's KOL Symposium Sheds New Light on the Importance of IL-12 Use Via OncoSec's Technology and Provides Updates on TAVO's Clinical Progress

Tavokinogene Telseplasmid “TAVO”

Taking the fight directly to the tumor

Through the intratumoral administration of IL-12, our lead product candidate, TAVO, may stimulate a safe but powerful systemic immune response leading to an innovative and potentially transformative therapy option for the treatment of cancer.

Learn More

Arming the Immune System to Fight Cancer

Clinical Pipeline

Pipeline
Our core technology platform continues to advance through clinical trials for various cancers.

Learn More

Technology

Technology
The Intratumoral IL-12 platform is designed to boost the immune system to recognize and attack tumors.

Learn More

Collaborators

Collaborators
OncoSec continues to establish relationships with industry leaders to further advance our research.

Learn More

IN THE CLINIC

Watch the Video

EXPLORE OUR TECHNOLOGY

Watch the Video

GUIDED BY SCIENCE

Visit the Site